Who
Eli Casdin
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Standard BioTools; Director and 10% owner, GeneDx Holdings; 10% owner, BioLife Solutions; Director, 2seventy bio; Director and 10% owner, SomaLogic; Officer (CEO), EQRx; Director and 10% owner, Tenaya Therapeutics; Director, Century Therapeutics.
In numbers
- Trades disclosed
- 180
- Buys
- 30
- Sells
- 3
- Bought
- $200.5M
- Sold
- $95.5M
- Companies
- 12
- Companies where not an officer
- 11
- First trade
- 26 Oct 2017
- Last trade
- 18 Jun 2026
- Last filed
- 23 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —99,116 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —175,923 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsoption or derivative · Life-science tools | SEC FORM 4 Code A | —175,923 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | —99,116 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —4,248 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code A | —4,248 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx Holdingsoption or derivative · Providers & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 18 Jun 2026filed 23 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Code M | —3,576 at $0.00 | filing |
| 5 Jun 2026filed 8 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Bought | $2.6M50,000 at $52.86 | filing |
| 4 Jun 2026filed 8 Jun 2026 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Bought | $8.5M150,000 at $56.44 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | $62K52,991 at $1.17 | filing |
| 26 Feb 2026filed 2 Mar 2026 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Code A | $62K52,991 at $1.17 | filing |
| 20 Nov 2025filed 20 Nov 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Bought | $585K450,000 at $1.30 | filing |
| 19 Nov 2025filed 20 Nov 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Bought | $448K350,000 at $1.28 | filing |
| 18 Nov 2025filed 20 Nov 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Bought | $338K275,000 at $1.23 | filing |
| 4 Sep 2025filed 5 Sep 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Bought | $320K250,000 at $1.28 | filing |
| 3 Sep 2025filed 5 Sep 2025 | LAB Standard BioToolsLife-science tools | SEC FORM 4 Bought | $318K250,000 at $1.27 | filing |
| 22 Aug 2025filed 22 Aug 2025 | WGS GeneDx HoldingsProviders & Facilities | SEC FORM 4 Sold | $60.5M500,000 at $120.90 | filing |
News
Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMEDLAB · manilatimes.net · 5 Oct 2026
0 headlines in the last 90 days name Eli Casdin; 1 article from the last 14 days about the 2 companies they traded most, at most three about any one of them.